NEW YORK, Aug. 23 (GenomeWeb News) - Discovery Partners International said today that it has been awarded a multi-year contract by the National Institutes of Health to establish and maintain a small molecule repository for up to one million chemical compounds that will be provided to NIH screening centers under the NIH Roadmap.
The compounds stored in the repository are to come from a variety of sources, including commercial and academic ones, and will be used to screen known and novel targets by a consortium of chemical genomics screening centers.
According to DPI, the estimated funding of its contract for the base period between August 2004 and December 2008 is roughly $24 million. The repository will be housed with the company's chemistry division in San Francisco.
"We are extremely pleased to have been selected to provide such a critical function in the NIH Roadmap," Taylor Crouch, president and COO of DPI, said in a statement. "DPI will create a state of the art compound management facility for the NIH, which will be supported by our existing high-speed chemistry synthesis and analytical services."
Additional terms of the contract were not disclosed.